These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3228848)

  • 21. [Association between Class I HLA alleles and HBs antigen carrier status among blood donors in Senegal].
    Dieye A; Obami-Itou V; Barry MF; Raphenon G; Thiam A; Ndiaye R; Ndiaye M; Diaw ML; Diakhate L
    Dakar Med; 1999; 44(2):166-70. PubMed ID: 11957279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The intrahepatic expression of the hepatitis B virus in chronic delta hepatitis].
    Ramalho F; Velosa J; Costa A; Baptista A; de Moura MC
    Acta Med Port; 1993 May; 6(5):187-91. PubMed ID: 8337951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Investigation on human carriage of HBsAg in Qingtian County].
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Apr; 4(2):79-82. PubMed ID: 6883488
    [No Abstract]   [Full Text] [Related]  

  • 24. [A genetic epidemiologic study on HBsAg chronic carriers].
    Wang WJ; Xu HW; Men BY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Jun; 17(3):148-51. PubMed ID: 9208511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of 90 hepatitis B surface antigen carriers in Israel.
    Shouval D; Tur-Kaspa R; Adler R; Mani N; Penchas S; Roggendorf M; Frosner G; Eliakim M
    Isr J Med Sci; 1981 Jun; 17(6):407-12. PubMed ID: 7263200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Preliminary studies on HBsAg excretion from saliva in healthy carriers and epidemiological pattern of hepatitis B (author's transl)].
    Cao HL; Wang FL; Du XL; Chen SX; Wang Y; Liu CB
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1981 Sep; 3(3):179-82. PubMed ID: 6459179
    [No Abstract]   [Full Text] [Related]  

  • 27. [A prospective study of dynamic and epidemic factor of HBV infection in the army].
    Song QL
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 May; 27(3):162-4. PubMed ID: 8243181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
    Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
    J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological profiles of hepatitis B carrier patients in Singapore with special reference to the frequency and significance of concurrent presence of HBsAg and anti-HBs.
    Wang YM; Ng WC; Kang JY; Yap I; Seet BL; Teo J; Smith R; Guan R
    Singapore Med J; 1996 Apr; 37(2):150-2. PubMed ID: 8942251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis B viremia is associated with increased risk of hepatocellular carcinoma in chronic carriers.
    Tang B; Kruger WD; Chen G; Shen F; Lin WY; Mboup S; London WT; Evans AA
    J Med Virol; 2004 Jan; 72(1):35-40. PubMed ID: 14635008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis B infections in a multiracial New Zealand community.
    Milne A; Allwood GK; Moyes CD; Pearce NE; Lucas CR
    N Z Med J; 1985 Jul; 98(782):529-32. PubMed ID: 3861964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Etiology of hepatocellular carcinoma in Argentina: results of a multicenter retrospective study.
    Fassio E; Míguez C; Soria S; Palazzo F; Gadano A; Adrover R; Landeira G; Fernández N; García D; Barbero R; Perelstein G; Ríos B; Isla R; Civetta E; Pérez Ravier R; Barzola S; Curciarello J; Colombato LA; Jmeniltzky A
    Acta Gastroenterol Latinoam; 2009 Mar; 39(1):47-52. PubMed ID: 19408739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis of hepatitis B virus surface antigen carriers in relation to routine liver function tests: a prospective study.
    Sakuma K; Takahara T; Okuda K; Tsuda F; Mayumi M
    Gastroenterology; 1982 Jul; 83(1 Pt 1):114-7. PubMed ID: 7075936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predicting the development of hepatocellular cancer in hepatitis B carriers.
    De Mitri MS; Bernardi M
    Gut; 2008 Jan; 57(1):12-5. PubMed ID: 18094200
    [No Abstract]   [Full Text] [Related]  

  • 36. [A comparable study on characteristics of HBsAg carriers in rural areas of Shanghai, Tianjin and Taiyuan].
    Li JY; Lu YX; Bao ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Oct; 16(5):266-9. PubMed ID: 8706091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B infection in alcoholic liver disease and primary hepatocellular carcinoma in France.
    Goudeau A; Maupas P; Dubois F; Coursaget P; Bougnoux P
    Prog Med Virol; 1981; 27():26-34. PubMed ID: 6262868
    [No Abstract]   [Full Text] [Related]  

  • 38. [Epidemiological analysis of the etiological relationship between primary hepatocarcinoma and hepatitis B virus].
    Ding ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1984 Jun; 5(3):146-9. PubMed ID: 6097361
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interaction among the relative risk factors of primary liver cancer in a case-control study].
    Zhao N; Yu S; Sun WM
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Apr; 15(2):90-3. PubMed ID: 7923340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral pathogenesis of hepatocellular carcinoma in the United States.
    Liang TJ; Jeffers LJ; Reddy KR; De Medina M; Parker IT; Cheinquer H; Idrovo V; Rabassa A; Schiff ER
    Hepatology; 1993 Dec; 18(6):1326-33. PubMed ID: 8244256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.